Takip et
Robin Jones
Robin Jones
ROYAL MARSDEN AND INSTITUE OF CANCER RESEARCH
doctors.org.uk üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
P Malfertheiner, F Megraud, C O’Morain, F Bazzoli, E El-Omar, D Graham, ...
Gut 56 (6), 772-781, 2007
5454*2007
Pazopanib versus sunitinib in metastatic renal-cell carcinoma
RJ Motzer, TE Hutson, D Cella, J Reeves, R Hawkins, J Guo, P Nathan, ...
New England Journal of Medicine 369 (8), 722-731, 2013
20702013
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised …
DEMETRI G
LANCET 381, 295-302, 2013
14802013
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
A Halliday, M Harrison, E Hayter, X Kong, A Mansfield, J Marro, H Pan, ...
The Lancet 376 (9746), 1074-1084, 2010
10712010
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv51-iv67, 2018
8642018
Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized …
GD Demetri, M Von Mehren, RL Jones, ML Hensley, SM Schuetze, ...
Journal of Clinical Oncology 34 (8), 786, 2016
8172016
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
WD Tap, RL Jones, BA Van Tine, B Chmielowski, AD Elias, D Adkins, ...
The Lancet 388 (10043), 488-497, 2016
6592016
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv68-iv78, 2018
5742018
Raman techniques: fundamentals and frontiers
RR Jones, DC Hooper, L Zhang, D Wolverson, VK Valev
Nanoscale research letters 14, 1-34, 2019
5672019
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
F Grosso, RL Jones, GD Demetri, IR Judson, JY Blay, A Le Cesne, ...
The lancet oncology 8 (7), 595-602, 2007
5372007
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
534*2021
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ...
Annals of Oncology 29, iv79-iv95, 2018
5222018
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ...
Annals of Oncology 32 (11), 1348-1365, 2021
4822021
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
DSP Tan, C Marchió, RL Jones, K Savage, IE Smith, M Dowsett, ...
Breast cancer research and treatment 111, 27-44, 2008
4402008
Differential sensitivity of liposarcoma subtypes to chemotherapy
RL Jones, C Fisher, O Al-Muderis, IR Judson
European journal of cancer 41 (18), 2853-2860, 2005
3992005
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma …
T Powles, MS van der Heijden, D Castellano, MD Galsky, Y Loriot, ...
The Lancet Oncology 21 (12), 1574-1588, 2020
3832020
An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between sarcoma PAtients EuroNet (SPAEN) and European organization for …
B Kasper, C Baumgarten, J Garcia, S Bonvalot, R Haas, F Haller, ...
Annals of Oncology 28 (10), 2399-2408, 2017
3782017
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
RL Jones, J Salter, R A’Hern, A Nerurkar, M Parton, JS Reis-Filho, ...
Breast cancer research and treatment 116, 53-68, 2009
3442009
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
JY Blay, C Serrano, MC Heinrich, J Zalcberg, S Bauer, H Gelderblom, ...
The Lancet Oncology 21 (7), 923-934, 2020
3232020
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity
V Almendro, YK Cheng, A Randles, S Itzkovitz, A Marusyk, E Ametller, ...
Cell reports 6 (3), 514-527, 2014
3192014
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20